Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
The use of hematopoietic stem cells in autoimmune diseases.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
JC polyomavirus mutants escape antibody-mediated neutralization.
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
[Immunomodulation and neuroprotection in optic neuritis].
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Extended interval dosing of natalizumab in multiple sclerosis.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.

Pages